Black Diamond Therapeutics, Inc. (BDTX) vs Foghorn Therapeutics Inc. (FHTX)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and Foghorn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FHTX
Foghorn Therapeutics Inc.
$2.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BDTX vs FHTX
growth of $100 · dividends reinvested · last 6yBDTX -93.9% (-37.3%/yr)FHTX -89.0% (-30.7%/yr)FHTX compounded faster over this window
BDTX FHTX
BDTX vs FHTX: by the numbers
- •FHTX is the larger company ($117M vs $111M market cap).
- •BDTX is profitable (31.95% net margin) while FHTX runs a net loss (-175.78%).
Metrics side by side
Valuation
| Metric | BDTX | FHTX |
|---|---|---|
| P/S ratio | N/A | 3.20 |
| P/B ratio | 1.16 | N/A |
Profitability
| Metric | BDTX | FHTX |
|---|---|---|
| Gross margin | 99.54% | 89.22% |
| Operating margin | 28.39% | -265.64% |
| Net margin | 31.95% | -175.78% |
| ROE | -44.29% | N/A |
| ROIC | -47.54% | -44.81% |
Growth (annualized)
| Metric | BDTX | FHTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.83% |
| Total return CAGR (5Y) | -24.47% | -31.87% |
Frequently asked
- Is BDTX or FHTX more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus FHTX at -175.78%.
- How have BDTX and FHTX total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and FHTX delivered -31.87% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Black Diamond Therapeutics ROEFoghorn Therapeutics ROEBlack Diamond Therapeutics operating marginFoghorn Therapeutics operating marginBlack Diamond Therapeutics revenue growthFoghorn Therapeutics revenue growthBlack Diamond Therapeutics free cash flowFoghorn Therapeutics free cash flow
Black Diamond Therapeutics & Foghorn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.